Promising Publication: The Novel Schizophrenia Treatment Gaining Traction

Video

Data published in The New England Journal of Medicine shows promise for a novel schizophrenia treatment.

Stephen Brannan, MD, Chief Medical Officer of Karuna Therapeutics, talks more on the phase II clinical data for KarXT, published in the New England Journal of Medicine.

To read more, see Journal Publication Brings Good News for Novel Schizophrenia Treatment.

Dr Brannan is chief medical officer at Karuna Therapeutics and a neuroscience drug development expert.

Related Videos
“What we’re striving to do is conquer the unmet needs that are still here with treating ADHD, especially from a medication standpoint.”
Work takes up one-third of a patient’s life—it is important that we pay attention to it.
A new treatment in development is poised to be a game-changer for patients with postpartum depression.
An expert discusses the latest on EndeavorRx and more digital therapeutics for this patient population.
Related Content
constipation

Constipation Conundrum: A Case of Clozapine-Associated Pseudo-Obstruction and Ogilvie Syndrome

November 28th 2023
Article
Treating ‘Morally Objectionable’ Patients

Treating ‘Morally Objectionable’ Patients

September 27th 2021
Podcast
From neurological abnormalities in first-episode psychosis to psychiatric boarding in emergency departments, here are highlights from the week in Psychiatric Times.

The Week in Review: November 6-10

November 11th 2023
Article
More Than Postpartum Depression: Addressing Maternal Mental Health Through the Life Cycle

More Than Postpartum Depression: Addressing Maternal Mental Health Through the Life Cycle

May 11th 2021
Podcast
These results were instrumental in securing the FDA approval of the drug for the treatment of schizophrenia in adults in April 2023.

Study Finds That Long-Acting Schizophrenia Treatment Prolongs Time to Impending Relapse

November 7th 2023
Article
From sleep and neuroendocrine function following TBI to new phase 3 results from a clinical trial evaluating a promising new schizophrenia treatment, here are highlights from the week in Psychiatric Times.

The Week in Review: October 30-November 3

November 4th 2023
Article
© 2023 MJH Life Sciences

All rights reserved.